CAMK2G and Optic neuropathy: Understanding the underlying mechanisms of CaMKII action in RGCs will be key to deriving strategies that promote RGC survival without compromising axon regeneration, an important goal in light of the profound neuroprotection that may be provided by CaMKII gene therapy in optic neuropathies.